Effect of TDF Monotherapy PrEP on Immune Function in Seroconverting Individuals
Background: Tenofovir disoproxil fumarate (TDF) has been used in all major published clinical trials of HIV pre-exposure prophylaxis (PrEP), and is a component of the only drug (TDF/emtricitabine) currently approved for PrEP. However, little is known about the effect of TDF monotherapy on individuals seroconverting while receiving PrEP. We examined immune functions in Bangkok Tenofovir…